Table 4.
SAVE28 2013 | Ibrahim et al21 | SAVE 229 2016 | SAKURA27 2016 | |
---|---|---|---|---|
“Was the study described as randomized?” | Y | Y | Y | Y |
“Was the randomization protocol detailed and appropriate?” | Y | Y | Y | Y |
“Was the study described as double-blind?” | N | N | N | Y |
“Was the blinding process detailed and appropriate?” | N | N | N | Y |
“Did the study have a control group?” | Y | Y | Y | Y |
“Was the control detailed and appropriate?” | N | N | Y | Y |
“Was there an adequate exclusion criterion?” | Y | Y | Y | Y |
“Was the intervention used at a therapeutic dose?” | Y | Y | Y | Y |
“Was there a description of withdrawals and dropouts?” | Y | Y | Y | Y |
“Were the data clearly and adequately reported?” | Y | Y | Y | Y |
Score (total =10) | 7 | 7 | 8 | 10 |
Note: Ibrahim et al21 is a follow-up study of the SAVE trial.
Abbreviation: RCT, randomized controlled trial.